Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Junya Ohmori"'
Publikováno v:
The Proceedings of the Bioengineering Conference Annual Meeting of BED/JSME. :223-224
Autor:
Shoko Tada, Junya Ohmori, Kyoichi Maeno, Mitsuyuki Matsumoto, Kazuyuki Hidaka, Tokio Yamaguchi
Publikováno v:
NeuroReport. 7:2543-2546
We investigated some in vitro pharmacological properties of a novel human dopamine D2-like receptor antagonist, YM-50001 [(R)-5-chloro-4-cyclopropylacarbonylamino-2-methoxy-N-[1-(3-methox ybenzyl)- 3-pyrrolidinyl]benzamide monooxalate]. Receptor bind
Autor:
Yoshikazu Tasaki, Tokio Yamaguchi, Mitsuyuki Matsumoto, Shoko Tada, Junya Ohmori, Kazuyuki Hidaka, Tamako Nomura, Shinji Usuda
Publikováno v:
British Journal of Pharmacology. 117:1625-1632
1. We investigated some neurochemical properties of a novel benzamide, YM-43611, [(S)-N-(1-benzyl-3-pyrrolidinyl)-5-chloro-4-cyclopropylcarbonylamino+ ++-2- methoxybenzamide] in comparison with putative D2-like receptor antagonists using both rat and
Publikováno v:
Journal of Medicinal Chemistry. 39:1331-1338
We have synthesized and evaluated azaquinoxalinediones 3a-c for their activity in inhibiting [3H]AMPA binding from rat whole brain. It was found that the azaquinoxalinedione nucleus functions as a bioisostere for quinoxalinedione in AMPA receptor bin
Publikováno v:
Journal of Medicinal Chemistry. 39:3971-3979
As part of our study of novel antagonists at the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) subtype of excitatory amino acid (EAA) receptors and the pharmacophoric requirements of the receptor, we designed and synthesized a series of
Autor:
Kiyoshi Murase, Toshio Furuya, Masao Shimizu-Sasamata, Junzi Togami, Junya Ohmori, Sachiko Kawasaki, Kazuyuki Hidaka, Shuichi Sakamoto, Hirokazu Kubota, Masamichi Okada
Publikováno v:
Journal of Medicinal Chemistry. 37:467-475
A novel series of quinoxalinediones possessing imidazolyl and related heteroaromatic substituents was synthesized and evaluated for their activity to inhibit [ 3 H]AMPA binding from rat whole brain. From the structure-activity relationships, it was f
Publikováno v:
The Proceedings of The Computational Mechanics Conference. :149-150
Publikováno v:
ChemInform. 27
We have synthesized and evaluated azaquinoxalinediones 3a-c for their activity in inhibiting [3H]AMPA binding from rat whole brain. It was found that the azaquinoxalinedione nucleus functions as a bioisostere for quinoxalinedione in AMPA receptor bin
Publikováno v:
ChemInform. 28
As part of our study of novel antagonists at the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) subtype of excitatory amino acid (EAA) receptors and the pharmacophoric requirements of the receptor, we designed and synthesized a series of
Autor:
Shinji Usuda, Kazuhiro Nakato, Junya Ohmori, Mitsuyuki Matsumoto, Kyoichi Maeno, Shoko Tada, Shin-ichi Tsukamoto, Toshiyasu Mase, Hanae Hattori, Shuichi Sakamoto, Kazuyuki Hidaka
Publikováno v:
ChemInform. 27
In this study, we synthesized a series of (S)-N-(3-pyrrolidinyl)benzamide derivatives, 1, 2a−d, 5a−l, and 7, and their enantiomers, (R)-1 and (R)-5c−e, and evaluated their binding affinity for cloned dopamine D2, D3, and D4 receptors and their